About Vector Core

High Quality Research-Grade Viral Vectors

The Gene Transfer Vector Core (GTVC) is a viral vector core facility located at Schepens Eye Research Institute that offers the production of high titer, research-grade recombinant adeno-associated virus (rAAV). The GTVC is an integral part of the Grousbeck Gene Therapy Center, Ocular Genomics Institute of Harvard Medical School, and Massachusetts Eye and Ear Infirmary.

Our primary goal is to provide high-quality viral vectors and supporting services to the research community in Boston and beyond to support preclinical gene therapy studies.

To view services and place an order, please visit: Gene Transfer Vector

Our Services Include:

Our services include:

  • Manufacturing of high titer, high-quality, research-grade recombinant adeno-associated virus (rAAV)
  • Quality control measures, including quantification by ddPCR, purity analysis by SDS-PAGE, and more
  • An extensive inventory of ready-to-ship vectors of various serotypes with commonly used reporter genes
  • Consultation and assistance regarding vector design
  • Plasmid cloning and amplification
  • Complete plasmid sequencing